Madjdpour Caveh, Spahn Donat R, Weiskopf Richard B
Department of Anesthesiology, University Hospital (CHUV), Lausanne, Switzerland.
Crit Care Med. 2006 May;34(5 Suppl):S102-8. doi: 10.1097/01.CCM.0000214317.26717.73.
In the past, anemia in the perioperative period has been treated by red blood cell (RBC) transfusions relatively uncritically. RBC transfusions were believed to increase oxygen delivery by increasing hemoglobin concentration. Arbitrary transfusion triggers such as the "10/30 rule" (i.e., RBC transfusion indicated below a hemoglobin concentration of 10 g/dL or a hematocrit of 30%) were applied. However, there is now increasing evidence that RBC transfusions are associated with adverse outcomes and should be avoided whenever possible. Restraining from RBC transfusions and maintaining normovolemia in patients suffering from surgical blood loss results in acute anemia. Therefore, knowing the compensatory mechanisms during acute anemia is crucial. This review focuses on acute anemia tolerance, its limits, and physiologic transfusion triggers in the perioperative period.
过去,围手术期贫血相对不加区分地通过输注红细胞(RBC)进行治疗。人们认为输注RBC可通过提高血红蛋白浓度来增加氧输送。应用了诸如“10/30规则”(即血红蛋白浓度低于10 g/dL或血细胞比容低于30%时指示输注RBC)等任意输血触发阈值。然而,现在越来越多的证据表明,输注RBC与不良后果相关,应尽可能避免。对于手术失血患者,限制输注RBC并维持血容量正常会导致急性贫血。因此,了解急性贫血期间的代偿机制至关重要。本综述重点关注围手术期急性贫血耐受性、其限度以及生理性输血触发阈值。